Literature DB >> 23625936

Reply to Gonzalez-Serna et al.

Neeraj Sood, Zachary Wagner, Amber Jaycocks, Emmanuel Drabo, Raffaele Vardavas.   

Abstract

Mesh：

Year:  2013        PMID： 23625936      PMCID： PMC3703107          DOI： 10.1093/cid/cit261

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  "Test-and-treat" strategy for control of HIV and AIDS can lead to a decrease, not an increase, of multidrug-resistant viruses.

Authors:  A Gonzalez-Serna; V D Lima; J S Montaner; P R Harrigan; C J Brumme
Journal:  Clin Infect Dis       Date:  2013-04-26       Impact factor: 9.079

2.  HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Authors:  Raph L Hamers; Carole L Wallis; Cissy Kityo; Margaret Siwale; Kishor Mandaliya; Francesca Conradie; Mariette E Botes; Maureen Wellington; Akin Osibogun; Kim C E Sigaloff; Immaculate Nankya; Rob Schuurman; Ferdinand W Wit; Wendy S Stevens; Michèle van Vugt; Tobias F Rinke de Wit
Journal:  Lancet Infect Dis       Date:  2011-07-27       Impact factor: 25.071

3.  Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.

Authors:  Vivek Jain; Teri Liegler; Eric Vittinghoff; Wendy Hartogensis; Peter Bacchetti; Lauren Poole; Lisa Loeb; Christopher D Pilcher; Robert M Grant; Steven G Deeks; Frederick M Hecht
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

4.  Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection.

Authors:  Hong-Ha M Truong; Timothy A Kellogg; Willi McFarland; Brian Louie; Jeffrey D Klausner; Susan S Philip; Robert M Grant
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

5.  Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs.

Authors:  Bradley G Wagner; Sally Blower
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

6.  Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.

Authors:  Jeffrey A Johnson; Jin-Fen Li; Xierong Wei; Jonathan Lipscomb; David Irlbeck; Charles Craig; Amanda Smith; Diane E Bennett; Michael Monsour; Paul Sandstrom; E Randall Lanier; Walid Heneine
Journal:  PLoS Med       Date:  2008-07-29       Impact factor: 11.069
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.